A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.
about
Insulin-like growth factor and epidermal growth factor signaling in breast cancer cell growth: focus on endocrine resistant diseaseEvasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis.Regulatory effects of deguelin on proliferation and cell cycle of Raji cells.A novel antagonist to the inhibitors of apoptosis (IAPs) potentiates cell death in EGFR-overexpressing non-small-cell lung cancer cellsDeguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.Dalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.Deguelin Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells through Regulating the Expression of Galectin-1.Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells.Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin.Deguelin-induced blockade of PI3K/protein kinase B/MAP kinase signaling in zebrafish and breast cancer cell lines is mediated by down-regulation of fibroblast growth factor receptor 4 activity.Relevance of fruits, vegetables and flavonoids from fruits and vegetables during early life, mid-childhood and adolescence for levels of insulin-like growth factor (IGF-1) and its binding proteins IGFBP-2 and IGFBP-3 in young adulthood.Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer
P2860
Q26800001-7040D87E-D51A-434B-B6BD-6A53AECF27F1Q26827810-3DB9B0B1-B6C0-4D40-9801-93FD9E6E34D9Q33779169-10D37487-BA95-4932-9BAF-F2FCC458E2AAQ34886102-AE21E1A8-6727-4A9B-8360-C31AF594FB36Q35338435-73E51684-5D6C-4A56-A056-A540CD2B6A59Q35667885-D69B8724-E6E1-442C-BE82-B9FA38AE985FQ36382856-2B13FAA4-5FC9-4CFA-B909-490AA3944F24Q37012150-B3F494B9-B861-48DB-B22D-689A4313F9D9Q37228635-AB27F344-A972-4BA5-9975-3270035319DAQ37690896-62B72A65-17F7-4A25-8623-AFC824008F2DQ39382063-BBE768E2-BFAE-4BBD-B934-E717222D762DQ40251474-EF38F8E1-D459-4F53-8493-D936973F42A7Q58734093-FA2EC2BA-5B99-4CE5-9B66-87D2D23D0E5B
P2860
A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel antitumor activity of ...... 3 expression in breast cancer.
@ast
A novel antitumor activity of ...... 3 expression in breast cancer.
@en
type
label
A novel antitumor activity of ...... 3 expression in breast cancer.
@ast
A novel antitumor activity of ...... 3 expression in breast cancer.
@en
prefLabel
A novel antitumor activity of ...... 3 expression in breast cancer.
@ast
A novel antitumor activity of ...... 3 expression in breast cancer.
@en
P2093
P2860
P1433
P1476
A novel antitumor activity of ...... 3 expression in breast cancer.
@en
P2093
Ho-Young Lee
Hye Jeong Yun
Hye-Jin Boo
Hye-Young Min
Hyo-Jong Lee
Jai-Hyun Kim
Kyu-Won Kim
Myung A Sung
Sun-Hye Lee
Young-Ah Suh
P2860
P304
P356
10.1016/J.CANLET.2013.01.022
P407
P577
2013-01-21T00:00:00Z